Patent ID: 7795222

Claim:
A method for treating a corneal disorder comprising administering to a patient in need thereof a composition containing pharmaceutically effective amounts of (i) a peptide of which the amino acid sequence is Ser-Ser-Ser-Arg (SEQ ID NO: 1), Gly-Tyr-Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro-Gln-Thr (SEQ ID NO: 3), Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 4), Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 5), Gly-Ser-Ser-Ser-Arg (SEQ ID NO: 6), Gly-Ser-Ser-Ser-Arg-Arg (SEQ ID NO: 7), Ala-Ser-Ser-Ser-Arg-Arg-Ala-Pro (SEQ ID NO: 8), Gly-Ser-Ser-Ser-Arg-Ala-Ala-Pro (SEQ ID NO: 9), Gly-Ser-Ser-Ser-Arg-Ala-Ala-Ala-Pro (SEQ ID NO: 10) or a pharmaceutically acceptable salt thereof and (ii) a peptide of which the amino acid sequence is —NH 2 Phe-Gly-Leu-Met-NH 2 (SEQ ID NO: 2), substance P or a pharmaceutically acceptable salt thereof, together with a pharmaceutically acceptable carrier.